What is Arcutis Biotherapeutics, Inc.'s net change in cash?

Arcutis Biotherapeutics, Inc. (ARQT) reported net change in cash of -$8.15M in Q1 2026.

How has Arcutis Biotherapeutics, Inc.'s net change in cash changed year-over-year?

Arcutis Biotherapeutics, Inc.'s net change in cash increased by 55.3% year-over-year, from -$18.23M to -$8.15M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Arcutis Biotherapeutics, Inc. ARQT Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

AmgenAMGN

$2.91B+192%

IncyteINCY

$363.28M+43.1%

OrganonOGN

$542M+523%

Kymera TherapeuticsKYMR

-$212.91M-603%

Kiniksa Pharmaceuticals International, plcKNSA

$24.36M+192%

Other financials

Income statement

See full

Revenue$105.4M+60.1%

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.28B+57.5%

Enterprise value$3.36B+57.0%

P/S7.9×-1.9×

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s net change in cash?: Arcutis Biotherapeutics, Inc. (ARQT) reported net change in cash of -$8.15M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s net change in cash changed year-over-year?: Arcutis Biotherapeutics, Inc.'s net change in cash increased by 55.3% year-over-year, from -$18.23M to -$8.15M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.